Narcotics Analgesics Market Outlook:
Narcotics Analgesics Market size was valued at USD 31.61 billion in 2025 and is expected to reach USD 51.98 billion by 2035, registering around 5.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of narcotics analgesics is assessed at USD 33.06 billion.
The growth of the market can be attributed to the rise in the research and development of narcotics analgesics worldwide. Further, the increased use of heroin, a type of narcotic analgesic, is also expected to contribute to market growth. In 2019, more than 40,000 people tried heroin for the first time and in 2020, around 7,00,000 people used heroin. Besides this, the rise in concern for the misuse of pain killers and the myth that pure heroin is less harmful than less pure heroin forms is also poised to create numerous opportunities for market growth in the coming years. Also, a growing tolerance to non-narcotics analgesics is the major reason for the constant increase in sales of narcotics analgesics.
In addition to these, factors that are believed to fuel the market growth of narcotics analgesics include the quick onset of action of these pharmaceutical drugs and the high efficiency of these drugs for neuropathic pain management. In addition to this, the rise in demand for drugs for pain relief related to the central nervous system (CNS), such as morphine, is also anticipated to drive market growth. International Narcotics Control Board reported that 79% of the world’s population consumed 13% of morphine used for the management of pain and suffering or 1% out of 388.2 tons of total morphine manufactured across the world.
Key Narcotics Analgesics Market Insights Summary:
Regional Highlights:
-
North America narcotics analgesics market is anticipated to secure a lucrative share by 2035, driven by increased consumption of opioids for both medical and non-medical purposes.
-
Segment Insights:
- The oral segment of the narcotics analgesics market is projected to capture a remarkable revenue share by 2035, owing to its non-invasive administration, ease of use, and higher efficiency compared to other routes.
- The pain management segment is poised to hold a substantial share by 2035, fueled by the rising global prevalence of cancer and cardiovascular diseases.
Key Growth Trends:
- Increased Research for Cancer Treatment Drugs
- Rising Consumption of Different Types of Drugs
Major Challenges:
- Addiction to Narcotics Drugs
- Shortage of Analgesic Medication
Key Players: Chang Chun Group, Vertex Chem Private Limited, DIC Corporation, Wacker Chemie AG, Nissin Chemical Industry Co., Ltd., Mitsui Chemicals, Inc., Arakawa Chemical Industries. Ltd., Papertex Speciality Chemicals Pvt. Ltd., SHOWA HIGH POLYMER SINGAPORE PTE LTD, Melamin dd Kocevje.
Global Narcotics Analgesics Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 31.61 billion
- 2026 Market Size: USD 33.06 billion
- Projected Market Size: USD 51.98 billion by 2035
- Growth Forecasts: 5.1% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (36% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Switzerland, Japan, France
- Emerging Countries: China, India, Japan, South Korea, Brazil
Last updated on : 25 February, 2026
Narcotics Analgesics Market - Growth Drivers and Challenges
Growth Drivers
- Increased Research for Cancer Treatment Drugs – Narcotics analgesics is the new approach for the treatment of cancer patients, the medication developed from opioids is highly used for cancer treatment. Therefore, rising investment is to augment the development of more effective drugs. As per the National Cancer Institute, the funding for cancer research increased from USD 4,952.6 in 2015 to USD 6,440.4 in 2019.
- Increase in Incidence of Chronic Diseases such as Cancer, Heart Disorders, Arthritis, and Tuberculosis – The unhealthy lifestyle has led to an increase of chronic diseases among the population. As a result of rising diagnosis of high number of chronic diseases is expected to increase the adoption of narcotics analgesics in the healthcare sector. As they are extensively used for managing the main that cannot be reduced by the use of normal painkillers. About 60 million adults have arthritis in the U.S, which is about 1 in 4 adults.
- Rising Consumption of Different Types of Drugs –Rising drug consumption in the world can create good opportunities for the increased use of narcotics analgesics. In the year 2020, the use of different types of drugs increased by more than 20% from 2010 during the COVID-19 pandemic.
- Increasing Dispensing Rates of Opioids – Opioids are a type of medication used to treat moderate to severe pain. Opioids can be developed in the laboratory or from the opium poppy plant. They function by binding to opioid receptors on nerve cells in the brain, gastrointestinal system, spinal cord, and other organs to suppress pain signals. Some opioids may be used to treat cough and diarrhea as well. For instance, in 2020, over 3% of U.S countries dispensed adequate opioid prescriptions for every individual to have one. Further, the overall dispensing rate in the U.S in the same year was over 40 prescriptions per 100 people, while some countries had nine times higher rates.
- Government Support to Improve Pharmaceutical and Analgesic Industries – Rising spending on pharmaceuticals can boost the advancement of new forms of drugs including those made from the base of narcotics. The estimated R&D expenditure in the pharmaceutical industry in 2019 was more than USD 80 billion.
Challenges
- Addiction to Narcotics Drugs – Narcotics drugs such as heroines can be highly addictive if consumed once. Addiction can further push individuals into serious disorders like substance abuse in the longer run. Their misuse, abuse, and use beyond of prescribed medical purposes can result in opioid dependence and other health issues. The World Health Organization estimates that drug usage is responsible for around half a million fatalities worldwide.
- Shortage of Analgesic Medication
- Imposed Regulations to Prevent Misuse
Narcotics Analgesics Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
5.1% |
|
Base Year Market Size (2025) |
USD 31.61 billion |
|
Forecast Year Market Size (2035) |
USD 51.98 billion |
|
Regional Scope |
|
Narcotics Analgesics Market Segmentation:
Administration Route Segment Analysis
By 2035, oral segment in narcotics analgesics market is expected to capture remarkable revenue share, attributed to the simple administration through the oral route, the non-invasive nature of administration, and the increased efficiency of these drugs when compared to other routes of administration. Over 80% of drugs in high demand are oral route products with a value of USD 30 billion and a growth rate of 10% annually.
Application Segment Analysis
By 2035, pain management segment in narcotics analgesics market is poised to capture substantial revenue share. Narcotics analgesics are highly used to relieve pain killer, these drugs can be really effective in reducing the pain in the patients suffering from cancer and cardiovascular issues. Therefore, the rising cases of cancer and heart patients is expected to boost the segment growth. According to the World Cancer Research Fund International in 2020, there were 18.1 million new cases of cancer worldwide. 9.3 million of these instances involved men, while 8.8 million involved women. Furthermore, one in fourteen persons worldwide suffers from a heart or circulatory illness. Moreover, according to current estimates, there are around 290 million women and nearly 260 million men suffering from heart and circulation illnesses worldwide.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By Administration Route |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Narcotics Analgesics Market - Regional Analysis
North American Market Insights
By the end of 2035, North American region is anticipated to hold lucrative narcotics analgesics market share, attributed majorly to the increased consumption of opioids for both medical and non-medical purposes. Over 80% of the world's opioids are consumed in the United States, which has 4.4% of the world's population. About 99% of the hydrocodone used worldwide is used in the US. Moreover, between 2015-2018 about 10.7% of U.S adults aged 20 and above used one or more prescription pain medications (opioid or nonopioid) and 5.7% used one or more prescription opioids, as per the statistics by the Centers for Disease Control and Prevention (CDC). Furthermore, rising cases of arthritis and osteoarthritis in the region are also expected to augment the market growth. In 2020, every 1 in 4 adults in the United States are suffering from arthritis, further, it is estimated around 27 million adults in the region are likely to have arthritis by 2040. In addition to this, the most prevalent joint condition in the US is osteoarthritis. More than 33 million American people will have osteoarthritis by 2020.
Narcotics Analgesics Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Abbott Laboratories
- Janssen Global Services, LLC
- Novartis AG
- Bayer AG
- GlaxoSmithKline plc
Recent Developments
-
Johnson & Johnson Services, Inc. announced a settlement agreement with the State of New York and its subdivisions, resolving their opioid-related claims against the Company. The settlement will provide about USD 263 million in funding for New York and its subdivisions to address opioid-related issues and as reimbursement for attorney fees and costs.
-
AbbVie Inc. in association with Neurocrine Biosciences, Inc. announced the release of first and only gonadotropin-releasing hormone ORILISSA that has been approved by the U.S Food and Drug Administration.
- Report ID: 4203
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Narcotics Analgesics Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
